> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Philips Recalls ECG Mobile Monitoring App
- URL: https://www.fdaweb.com/philips-recalls-ecg-mobile-monitoring-app/
- Published: 2025-01-13T12:00:00.000Z
- Updated: 2026-09-14T14:50:45.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158471

Philips and its subsidiary Braemar Manufacturing are recalling (Class 1 device correction) their Monitoring Service Application concerning the Mobile Cardiac Telemetry Monitoring (BTPS-1000) system after identifying that some electrocardiogram (ECG) events received were not properly routed. “As a result, these events were not reviewed by a cardiology technician for potential reporting to the ordering clinician,” a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/outpatient-telemetry-correction-philips-issues-correction-monitoring-service-application-used-mobile?utm%5Fmedium=email&utm%5Fsource=govdelivery) says, adding that this may have led to missing information impacting a healthcare provider’s clinical decision-making.

Some of the ECG events received met criteria to be “escalated” back to ordering physicians, but were never re-routed to them, according to the notice. “These events include algorithm-identified episodes of atrial fibrillation or pause, supraventricular tachycardia, ventricular tachycardia, and second or third degree AV \[atrioventricular\] block,” it says.

To date FDA says it is aware of 109 reported injuries and two reports of death related to the issue.

The software in the app is intended to process, analyze, display, and report symptomatic and asymptomatic cardiac events in ECG data received from compatible devices, FDA says, adding that the data are then transmitted to qualified healthcare professionals for their review and follow-up.